
Coexistence of Hereditary Spastic Paraplegia Type 4 and Narcolepsy: A Case Report
Author(s) -
Nagai Takahiro,
Sunami Yoko,
Kato Risa,
Sugai Megumi,
Takahara Makoto,
Ohta Kentaro,
Fujinaka Hidehiko,
Goto Kiyoe,
Okanura Osamu,
Nakajima Takashi,
Ozawa Tetsuo
Publication year - 2021
Publication title -
case reports in neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.207
H-Index - 15
ISSN - 1662-680X
DOI - 10.1159/000512404
Subject(s) - single case – general neurology
Spastic paraplegia type 4 (SPG4) is the most common type of hereditary spastic paraplegia (HSP) caused by the mutations in the SPAST gene, which encodes a microtubule-severing protein named spastin. Spastin regulates the number and mobility of microtubules and is essential for axonal outgrowth and neuronal morphogenesis. Herein, we report a patient with SPG4 harboring a novel donor splice site mutation in the SPAST gene (c.1616+1dupG). Although SPG4 usually manifests itself as a pure form of HSP, this patient exhibited a slow progressive cognitive decline and also developed narcolepsy type 2 (narcolepsy without cataplexy) prior to the onset of SPG4. Recently, cognitive decline has attracted attention as a main non-motor symptom of SPG4. However, this is the first reported case of a patient developing both SPG4 and narcolepsy, although it remains unclear whether the manifestation of the two diseases is a coincidence or an association. In this report, we describe the clinical symptoms and genetic background of the patient.